This area is reserved for registered users. Please register or login.

Vesomni – Treatment of storage and voiding symptoms associated with benign prostatic hyperplasia

Astellas wish to announce that Vesomni, a fixed-dose combination (FDC) tablet containing the active ingredients solifenacin (antimuscarinic) plus tamsulosin (alpha-blocker), is now available in Ireland. It is indicated for the treatment of moderate to severe storage symptoms (urgency, increased micturition frequency) and voiding symptoms associated with benign prostatic hyperplasia (BPH) in men who are not adequately responding to treatment with monotherapy.1   Lower urinary tract symptoms (LUTS) associated with BPH are common in men and can include storage symptoms (frequency, urgency, nocturia) and/or voiding symptoms (e.g. hesitancy, intermittency).2,3 Storage and voiding symptoms are attributed to the bladder and prostate, respectively.…